TriClip™ Tricuspid Valve Repair

TRICLIP™
TRICUSPID
VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

Build upon clip-based platform, TriClip™ Transcatheter Edge-to-Edge-Repair (TEER) offers a minimaly invasive treatment option for patients with symptomatic, severe Tricuspid Regurgitation (TR) who are at high risk for surgery.

Discover why Experience Matters

WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE

FIND OUT MORE:

DOWNLOAD FLYER

SPECIALLY DESIGNED FOR THE TRICUSPID VALVE¹

TriClip™ Transcatheter Edge-to-Edge (TEER) offers unmatched stability, precision, and control^2* required for the unique challenges of the tricuspid anatomy to acheive sustained, clinically significant improvements in the lives of patients with Tricuspid Regurgitation.^3,4

Significant TR reduction^3-5
Strong safety profile^3-5
Life changing improvements in health related quality of life^3-5
Proven in randomized and real-world studies.^3-5

*Based on Abbott simulated horizontal tensile testing

FIND OUT MORE ABOUT:

TRICUSPID REGURGITATION TREATMENT OPTIONS CLINICAL DATA PCR London Valves 2023

TV

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

T-TEER: echo procedural approach

T-TEER: echo procedural approach for Transcatheter Tricuspid Repair

T-TEER: patient selection and current evidence

T-TEER: patient selection and current evidence for TR Repair

Anatomical overview of the AV Valves

Anatomical overview of the AV Valves and structures

Screening Transmission | Mitral focus

Screening Transmission | Mitral focus

F. Maisano, M. Swaans, M. Adam. M. Weber

TriClip - AVVS 1 year 1 minute Tricuspid - Video

The most significant moments of the past year | Tricuspid focus

MitraClip - AVVS 1 year 1 minute Mitral - Video

The most significant moments of the past year | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

AV Valves Summit 2024 | Closing of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Trending Controversies | AV Valves

Trending Controversies | AV Valves

R. S. Von Bardeleben, M. Sitges, D. Tchetche, M. Swaans, M. Taramasso, C. Trani, K. Gatenby, M. Adamo, M. Barreiro, A. Linke, V. Ninios, J. Odenstedt, S. Berti, N. Ajmone Marsan

Case Parade | Mitral focus

Case Parade | Mitral focus

M. Sitges, V. Ninios, J. Van der Heyden, K. Gatenby, D. Arzamendi, M. Shuvy, M. Adam

References

Data on file at Abbott.
Tests(s) performed and data on file at Abbott (RPT2118537)
von Bardeleben RS, Lurz P, Sitges M, et al. Percutaneous edge-to-edge repair for tricuspid regurgitation: 2-year outcomes from the TRILUMINATE trial. Presented at EuroPCR 2021.
Lurz P, Schueler R, Goebel B, et al. Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip™ bRIGHT Study. Presented at PCR London Valves 2021.
Lurz P, von Bardeleben RS, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229–239. doi.org/10.1016/j.jacc.2020.11.038.
Benfari G, Antoine C, Mille WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196-206.
Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935-2956.
Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis [published online ahead of print November 9, 2019]. Prog Cardiovasc Dis. 2019;62(6):447-451. Doi:10.1016/j.pcad.2019.10.009.
Wong WK, Chen SW, Chou AH, et al. Late outcomes of valve repair versus replacement in isolated and concomitant tricuspid valve surgery: a nationwide cohort study. J Am Heart Assoc. 2020;9(8):e015637. doi:10.1161/JAHA.119.015637.
Moraca RJ, Moon MR, Lawton JS, Guthrie TJ, Aubuchon KA, Moazami N, Pasque MK, Damiano RJ Jr. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg. 2009 Jan;87(1):83-8; discussion 88-9.